Zhang H, et al. Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection. Bioorg Med Chem Lett. 2019 Aug 24:126639.
Exploration of the chemical space of known influenza polymerase PB2 inhibitor Pimodivir, was performed by our group. We synthesized and identified compounds 16a and 16b, two novel thienopyrimidine derivatives displaying anti-influenza A activity in the single digit nanomolar range in cell culture. Binding of these unique compounds in the influenza polymerase PB2 pocket was also determined using molecular modeling.
See Also:
Latest articles in those days:
- The surveillance programme for avian influenza (AI) in Norwegian wildlife 2025 3 hours ago
- The surveillance programme for avian influenza (AI) in poultry in Norway 2025 4 hours ago
- Emergence of Novel Reassortant H3N2 Avian Influenza Viruses in Southern China: Genetic Complexity and Pathogenicity in Chickens and Mice 4 hours ago
- Pathological evidence of neurotropism and oculotropism in wild black-headed gulls naturally infected with H5N1 high pathogenicity avian influenza 4 hours ago
- Birth cohort effects in adults associated with influenza A(H1N1)pdm09 vaccine effectiveness 16 hours ago
[Go Top] [Close Window]


